Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A paper by Oxford BRC-supported researchers says that linking research funding to Athena SWAN gender equality action plans has been associated with a rise in the number of women in mid-level leadership positions and the proportion of funding going to women.

Female scientist in the lab © Medical Sciences Division and John Cairns

The paper, published in the BMJ, said that more funders should trial funding incentives as they have been shown to work. The research team was led by Pavel Ovseiko, Senior Research Fellow in the Radcliffe Department of Medicine.

To accelerate women’s advancement and leadership, the National Institute for Health Research (NIHR) in 2011 linked its research funding to the implementation by universities of gender equality action plans through the Athena SWAN (Scientific Women’s Academic Network) charter.

In the 2016 round of the competition, the NIHR said it would not shortlist any research centre where the academic partners had not achieved at least the Athena SWAN silver award.

After the introduction of the Athena SWAN incentives, the proportion of female theme leads in BRCs increased from 8%in both 2006 and 2011 to 24% in 2016. The proportion of women in senior director positions also increased, albeit more modestly, from 11% in 2006 and 10% in 2011 to 15% in 2016.

The full story is available on the NIHR Oxford Biomedical Research Centre website

Similar stories

Oxford spinout trials revolutionary bioelectronic implant to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.

COVID-19 is a leading cause of death in children and young people in the US

A new study led by researchers at the University of Oxford’s Department of Computer Science has found that, between 2021 and 2022, COVID-19 was a leading cause of death in children and young people in the United States, ranking eighth overall. The results demonstrate that pharmaceutical and public health interventions should continue to be applied to limit the spread of the coronavirus and protect again severe disease in this age group.

Three or more concussions linked with worse brain function in later life

Experiencing three or more concussions is linked with worsened brain function in later life, according to new research.

New blood test could save lives of heart attack victims

Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.

COVID-19 increased public trust in science, new survey shows

A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.

Gero Miesenböck awarded 2023 Japan Prize

Congratulations to Professor Gero Miesenböck, Department of Physiology, Anatomy and Genetics (DPAG), who has been awarded the 2023 Japan Prize in the field of Life Sciences, together with Professor Karl Deisseroth, for pioneering work in the field of optogenetics.